A retrospective review of 218 consecutive nephrostomies done on uremic cancer patients has revealed an alarming incidence of postoperative morbidity and mortality. This review has raised legitimate questions regarding the value of palliatiave urinary diversion. A rationale to assist physicians in the management of this clinical problem is